VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
VBIV was delisted on the 7th of August, 2024.
24 hedge funds and large institutions have $63.9M invested in VBI Vaccines, Inc. New Common Stock (Canada) in 2017 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 5 closing their positions.
100% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 5
85% more capital invested
Capital invested by funds: $34.5M → $63.9M (+$29.4M)
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
14% more funds holding
Funds holding: 21 → 24 (+3)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$511K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$493K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
+$421K |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
+$340K |
| 5 |
Goldman Sachs
New York
|
+$314K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$326K |
| 2 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$33K |
| 3 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
-$29.5K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$17K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$9K |
VBIV Hedge Fund Activity: Q1 2017 in Review
24 of the 4,034 institutional investors tracked by Wall St. Rank reported a position in VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) for Q1 2017, worth a combined $63.9M — up 85% from $34.5M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new VBIV positions and 5 closed out — a net gain of 5 holders — while 5 added to existing stakes and 3 trimmed.
The largest buyer was Millennium Management, adding an estimated $511K. The largest seller was Vanguard Group, cutting an estimated $326K.
- 24 institutional investors held VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) as of Q1 2017, up from 21 in Q4 2016.
- Funds reported $63.9M of VBI Vaccines, Inc. New Common Stock (Canada) stock for Q1 2017, up 85% quarter-over-quarter.
- 10 funds opened new VBI Vaccines, Inc. New Common Stock (Canada) positions in Q1 2017 and 5 closed out, a net change of +5 holders.
- The largest VBI Vaccines, Inc. New Common Stock (Canada) buyer in Q1 2017 was Millennium Management, an estimated $511K added.
- The largest VBI Vaccines, Inc. New Common Stock (Canada) seller in Q1 2017 was Vanguard Group, an estimated $326K sold.
Based on aggregated 13F filings for Q1 2017.